Many researchers around the world are studying ultra-fine bubbles (nanobubbles) in hopes to uncover their hidden potential. Ultra-fine bubbles are much smaller than fine bubbles (microbubbles) which are used as contrast agents throughout the medical field today. This technology is currently at the center of the new concept called “Theranostics”, or the fusion of Diagnosis and Therapeutics. SonoCore will strive to lead the effort in developing new and innovative applications using ultra-fine bubbles for unmet needs in medicine.
|Company name||SonoCore, Inc.|
|Office||Mitsubishi Building 7F 2-5-2, Marunouchi, Chiyoda-ku, Tokyo, 100-0005, JAPAN|